Intravitreal Bevacizumab for Age-Related Macular Degeneration
Status:
Unknown status
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether intravitreal injection of bevacizumab is
effective in the treatment of neovascular age related macular degeneration